GELBOPHARMA: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
GELBOPHARMA
Largest movements
- Tangible fixed assets -€6,556
down €6,556 (-35.4%), from €18,535 to €11,979
of which Furniture and vehicles: -€3,335
- Trade debts -€12,395
down €12,395 (-16.4%), from €75,805 to €63,410
- Profit (loss) carried forward +€5,574
up €5,574 (+4.2%), from €132,916 to €138,490
- Taxes -€29,124
no longer reported in 2025 (was €29,124)
- Purchases and services -€19,111
down €19,111 (-2.6%), from €723,561 to €704,450
- Staff costs -€12,752
down €12,752 (-36.3%), from €35,124 to €22,373
- Gross operating margin +€11,376
up €11,376 (+37.0%), from €30,748 to €42,124
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €265,394 | €256,342 | -€9,052 | -3.4% |
| Fixed assets | 21/28 | €18,705 | €12,149 | -€6,556 | -35.1% |
| Tangible fixed assets | 22/27 | €18,535 | €11,979 | -€6,556 | -35.4% |
| Plant, machinery and equipment | 23 | €8,085 | €4,864 | -€3,221 | -39.8% |
| Furniture and vehicles | 24 | €10,451 | €7,115 | -€3,335 | -31.9% |
| Financial fixed assets | 28 | €170 | €170 | = | 0.0% |
| Current assets | 29/58 | €246,689 | €244,193 | -€2,496 | -1.0% |
| Stocks and contracts in progress | 3 | €100,181 | €100,818 | +€636 | +0.6% |
| Stocks | 30/36 | €100,181 | €100,818 | +€636 | +0.6% |
| Amounts receivable within one year | 40/41 | €90,024 | €87,500 | -€2,525 | -2.8% |
| Trade receivables | 40 | €73,527 | €68,773 | -€4,754 | -6.5% |
| Other amounts receivable | 41 | €16,497 | €18,727 | +€2,230 | +13.5% |
| Current investments | 50/53 | €38,056 | €38,056 | = | 0.0% |
| Cash at bank and in hand | 54/58 | €18,157 | €17,550 | -€607 | -3.3% |
| Deferred charges and accrued income | 490/1 | €270 | €270 | -€0 | 0.0% |
| Total equity and liabilities | 10/49 | €265,394 | €256,342 | -€9,052 | -3.4% |
| Equity | 10/15 | €167,376 | €172,950 | +€5,574 | +3.3% |
| Contributions | 10/11 | €32,600 | €32,600 | = | 0.0% |
| Reserves | 13 | €1,860 | €1,860 | = | 0.0% |
| Non-distributable reserves | 130/1 | €1,860 | €1,860 | = | 0.0% |
| Reserves not available under the articles | 1311 | €1,860 | €1,860 | = | 0.0% |
| Profit (loss) carried forward | 14 | €132,916 | €138,490 | +€5,574 | +4.2% |
| Amounts payable | 17/49 | €98,019 | €83,393 | -€14,626 | -14.9% |
| Amounts payable within one year | 42/48 | €98,019 | €83,393 | -€14,626 | -14.9% |
| Current portion of amounts payable after more than one year | 42 | €6,082 | €6,099 | +€17 | +0.3% |
| Financial debts | 43 | €0 | €0 | = | |
| Credit institutions | 430/8 | €0 | €0 | = | |
| Trade debts | 44 | €75,805 | €63,410 | -€12,395 | -16.4% |
| Suppliers | 440/4 | €75,805 | €63,410 | -€12,395 | -16.4% |
| Advances received on contracts in progress | 46 | €4,241 | €2,212 | -€2,028 | -47.8% |
| Taxes, remuneration and social security | 45 | €11,890 | €11,671 | -€219 | -1.8% |
| Taxes | 450/3 | €11,890 | €10,504 | -€1,387 | -11.7% |
| Remuneration and social security | 454/9 | €0 | €1,167 | +€1,167 | |
| Other amounts payable | 47/48 | €0 | €0 | = | |
| Turnover | 70 | €748,986 | €742,519 | -€6,467 | -0.9% |
| Goods, raw materials, services and sundry goods | 60/61 | €723,561 | €704,450 | -€19,111 | -2.6% |
| Remuneration, social security and pensions | 62 | €35,124 | €22,373 | -€12,752 | -36.3% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €10,542 | €9,599 | -€942 | -8.9% |
| Other operating charges | 640/8 | €1,761 | €1,684 | -€77 | -4.4% |
| Non-recurring operating charges | 66A | €124 | - | -€124 | |
| Gross operating margin | 9900 | €30,748 | €42,124 | +€11,376 | +37.0% |
| Operating profit (loss) | 9901 | -€16,803 | €8,468 | +€25,271 | |
| Financial income | 75/76B | €656 | €514 | -€142 | -21.7% |
| Recurring financial income | 75 | €656 | €514 | -€142 | -21.7% |
| Financial charges | 65/66B | €4,878 | €3,408 | -€1,470 | -30.1% |
| Recurring financial charges | 65 | €4,878 | €3,408 | -€1,470 | -30.1% |
| Profit (loss) for the period before taxes | 9903 | -€21,025 | €5,574 | +€26,599 | |
| Income taxes | 67/77 | €29,124 | - | -€29,124 | |
| Profit (loss) for the period | 9904 | -€50,149 | €5,574 | +€55,723 | |
| Profit (loss) for the period to be appropriated | 9905 | -€50,149 | €5,574 | +€55,723 |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 16 October 2026 via checked.be.